4//SEC Filing
Jindal Vineet R. 4
Accession 0001209191-21-069448
CIK 0001637715other
Filed
Dec 13, 7:00 PM ET
Accepted
Dec 14, 4:32 PM ET
Size
7.4 KB
Accession
0001209191-21-069448
Insider Transaction Report
Form 4
Jindal Vineet R.
Chief Financial Officer
Transactions
- Award
Common Stock
2021-12-10+30,000→ 36,600 total - Award
Stock option (right to buy)
2021-12-10+100,000→ 100,000 totalExercise: $6.69Exp: 2031-12-09→ Common Stock (100,000 underlying)
Footnotes (3)
- [F1]Represents a restricted stock unit award.
- [F2]Includes 1,600 shares acquired under the Issuer's 2021 Employee Stock Purchase Plan on December 8, 2021.
- [F3]The shares vest in a series of 48 successive equal monthly installments measured from December 10, 2021, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2021 Equity Incentive Plan) as of each such vesting date.
Documents
Issuer
Reneo Pharmaceuticals, Inc.
CIK 0001637715
Entity typeother
Related Parties
1- filerCIK 0001855115
Filing Metadata
- Form type
- 4
- Filed
- Dec 13, 7:00 PM ET
- Accepted
- Dec 14, 4:32 PM ET
- Size
- 7.4 KB